Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN116120183B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel axial and central chirality catalyst enables high enantioselectivity. Reduces costs in pharmaceutical intermediates manufacturing with scalable synthesis.